Literature DB >> 9651711

The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction.

S Wagner1, U Burczyk, R Schiele, C Bergmeier, J Rustige, M Gottwik, J Senges.   

Abstract

PURPOSE: The purpose of the study was to evaluate parameters that characterize patients with myocardial reinfarction as compared to patients with a first infarction in clinical practice, and possibly to determine their clinical outcome.
METHODS: The 60 minutes Myocardial Project is a German multicentre prospective observational study in which 136 hospitals are participating. Fourteen thousand, nine hundred and eighty consecutive patients with acute Q wave myocardial infarction were included from July 1992 to September 1994.
RESULTS: Out of these 14,980 patients, there were 2854 (19%) with reinfarction and 12,126 (81%) with a first infarction. Patients with a reinfarction arrived at the hospital 24 min earlier than patients with a first infarction (pre-hospital delay 156 vs 180 min; P < 0.001); the door-to-needle time with reinfarction was longer (38 vs 30 min; P < 0.001); however, patients with reinfarction were older (69 vs 66 years; P < 0.001), had a lower rate of a diagnostic first ECG (54 vs 71%; P < 0.001) and received thrombolytic therapy less frequently than patients with a first infarction (46 vs 52%; P < 0.001). A low number of patients received primary PTCA ( n = 205) since only a few hospitals offered a primary PTCA service at the time the study was performed. In patients with reinfarction, there were more reasons as to why thrombolytic therapy was not given (24 vs 21%; P < 0.001). Left bundle branch block occurred more frequently in patients with reinfarction (15 vs 8%; P < 0.001). The intra-hospital course in patients with reinfarction was associated with an increase of complications and intra-hospital death (23 vs 15%; P < 0.001.
CONCLUSIONS: Although reinfarction patients arrived earlier at hospital than patients with a first infarction, the former received thrombolytic therapy less frequently than the latter. Patients with reinfarction were older, more frequently had a non-diagnostic ECG on admission and had a higher rate of contraindications against thrombolytic therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9651711     DOI: 10.1053/euhj.1997.0864

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

Review 1.  [Thrombolysis in ST-elevation myocardial infarction. Current role in the light of recent studies].

Authors:  H-R Arntz; U Zeymer; P Schwimmbeck
Journal:  Anaesthesist       Date:  2004-05       Impact factor: 1.041

2.  TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Authors:  Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf
Journal:  Clin Res Cardiol       Date:  2012-05-06       Impact factor: 5.460

3.  Predictors and in-hospital prognosis of recurrent acute myocardial infarction.

Authors:  Cheng-Fu Cao; Su-Fang Li; Hong Chen; Jun-Xian Song
Journal:  J Geriatr Cardiol       Date:  2016-10       Impact factor: 3.327

4.  Comparison of clinical profiles and care for patients with incident versus recurrent acute coronary syndromes in France: Data from the MONICA registries.

Authors:  Suzanne Machta; Victoria Gauthier; Jean Ferrières; Michèle Montaye; Samantha Huo Yung Kai; Stefy Gbokou; Katia Biasch; Marie Moitry; Philippe Amouyel; Jean Dallongeville; Aline Meirhaeghe
Journal:  PLoS One       Date:  2022-02-14       Impact factor: 3.240

5.  When More Means Less: The Prognosis of Recurrent Acute Myocardial Infarctions.

Authors:  Ygal Plakht; Harel Gilutz; Arthur Shiyovich
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.